Alx Oncology Holdings Inc (ALXO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2020 | 12-2019 | 09-2019 | 06-2019 | 12-2018 | |
| Sales | 655 | 0 | 1,256 | 1,295 | 0 |
| Cost of Goods | 596 | N/A | 1,142 | 1,177 | N/A |
| Gross Profit | 59 | N/A | 114 | 118 | N/A |
| Operating Expenses | 5,897 | 0 | 3,290 | 4,484 | 0 |
| Operating Income | -5,242 | N/A | -3,034 | -4,189 | N/A |
| Interest Expense | 215 | 0 | 0 | 0 | 0 |
| Other Income | 7 | 0 | -2 | 0 | 0 |
| Pre-tax Income | -5,450 | 0 | -3,036 | -4,189 | 0 |
| Income Tax | 4 | N/A | 8 | 8 | N/A |
| Net Income Continuous | -5,454 | N/A | -3,044 | -4,197 | N/A |
| Net Income | $-5,454 | $N/A | $-3,044 | $-4,197 | $N/A |
| EPS Basic Total Ops | -2.37 | N/A | -1.33 | -1.68 | N/A |
| EPS Basic Continuous Ops | -1.74 | N/A | -0.98 | -1.36 | N/A |
| EPS Diluted Total Ops | -2.37 | N/A | -1.33 | -1.68 | N/A |
| EPS Diluted Continuous Ops | -1.74 | N/A | -0.98 | -1.36 | N/A |
| EBITDA(a) | $-5,021 | $N/A | $-2,923 | $-4,189 | $N/A |